Pharmacological treatment of depression
295 results
101 - 200
Psychosocial and psychological interventions for treating antenatal depression- Pharmacological interventions for self‐harm in adults
- Pharmacological interventions for treatment‐resistant depression in adults
- Interventions for fatigue in people with kidney failure requiring dialysis
Depression in adolescents - Pharmacological interventions for the treatment of disordered and problem gambling
- ADHD
- Milnacipran versus other antidepressive agents for depression
- Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
- Interventions for fear of childbirth including tocophobia
- Vortioxetine for depression in adults
- Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence
- Escitalopram versus other antidepressive agents for depression
- Behavioural activation therapy for depression in adults with non‐communicable diseases
- Pharmacological interventions for unilateral spatial neglect after stroke
- Psychosocial and psychological interventions for treating postpartum depression
- Antidepressants for cocaine dependence and problematic cocaine use: Cochrane systematic review
- Consultation liaison in primary care for people with mental disorders
- Treatment of epilepsy for people with Alzheimer's disease
- Antidepressant treatment for postnatal depression: Cochrane systematic review
- Prevention of depression in adults with long‐term physical conditions
- Music therapy for depression
- Excessive sweating (hyperhidrosis)
- Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents
- Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
- Non-pharmacological interventions for fatigue in rheumatoid arthritis: Cochrane systematic review
- Non-pharmacological interventions for chronic pain in people with spinal cord injury: Cochrane systematic review
- Therapeutic interventions for symptomatic treatment in Huntington's disease
- Cognitive behavioural interventions for sleep problems in adults aged 60+
- Physical exercise for sleep problems in adults aged 60+
- Pharmacological interventions for preventing post‐traumatic stress disorder (PTSD)
- Varenicline and bupropion and suicidal behaviour
- Pharmacological interventions for somatoform disorders in adults
- Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
- Exercise as adjunctive therapy for systemic lupus erythematosus
- Continuation and maintenance treatments for depression in older people
- Psychosocial interventions for the management of chronic orofacial pain: Cochrane systematic review
- Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
- Interventions for treating anxiety after stroke
- Interventions for self‐harm in children and adolescents
- Psychological therapies for treatment‐resistant depression in adults
- Rimonabant for overweight or obesity
- Antidepressants for the treatment of people with co-occurring depression and alcohol dependence: Cochrane systematic review
- Psychological interventions for depression and anxiety in patients with coronary heart disease, heart failure or atrial fibrillation
- Pharmacological interventions for people with borderline personality disorder
- Risperidone in long‐term treatment for bipolar disorder
- Duloxetine versus other anti‐depressive agents for depression
- Insulin for the treatment of women with gestational diabetes
- Amitriptyline for depression
- Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings: Cochrane systematic review
- Anticonvulsants for cocaine dependence
- Psychological therapies for depression in older adults residing in long‐term care settings
- Sequelae of traumatic brain injury
- Psychological treatment for anxiety in people with traumatic brain injury
- Antidepressants for anorexia nervosa
- Anxiety disorder
- Hydroxyzine for generalised anxiety disorder: Cochrane systematic review
- Interventions for preventing relapse or recurrence of major depressive disorder in adults in a primary care setting: a network meta‐analysis
- Interventions for self‐harm in children and adolescents
- Curable causes of cognitive challenges and memory disease
- Therapeutic touch for anxiety disorders
- Non‐pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults
- Lithium versus antidepressants in the long‐term treatment of unipolar affective disorder
- Migraine
- Perioperative pharmacological interventions for fetal immobilisation during fetal surgery and invasive procedures
- Fluvoxamine for the treatment of COVID‐19
- Antidepressants for smoking cessation
- Pharmacological interventions for those who have sexually offended or are at risk of offending
- Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents: Cochrane systematic review
- Antenatal clinics: care and examinations
- Antidepressants for pain management in rheumatoid arthritis: Cochrane systematic review
- Bipolar disorder
- Self‐help and guided self‐help for eating disorders
- Human chorionic gonadotrophin (hCG) for preventing miscarriage: Cochrane systematic review
- Adolescent substance abuse
- Morita therapy for anxiety disorders in adults: Cochrane systematic review
- Antidepressants for generalised anxiety disorder (GAD): Cochrane systematic review
- Mind‐body interventions during pregnancy for preventing or treating women's anxiety
- Drugs versus placebo for dysthymia: Cochrane systematic review
- Palliative treatment
- Treatment of a patient with memory disease
- Antidepressants versus placebo for people with bulimia nervosa
- Massage and touch for dementia
- Pharmacological treatments in panic disorder in adults: a network meta‐analysis
- Mirtazapine for fibromyalgia in adults
- Pharmacological treatment for familial amyloid polyneuropathy
- Psychosocial and pharmacological treatments for deliberate self harm: Cochrane systematic review